Methods
|
A placebo‐controlled trial conducted in Indonesia |
Participants
|
Inclusion criteria: All infants born at Hasan Sadikin Hospital in Bandung, Indonesia from June 18, 1992, to June 3, 1993 |
|
Exclusion criteria: Infants that were considered very low birthweight (<1500 g) and infants with life‐threatening conditions |
|
Total number randomized in the intervention group: 1034 |
|
Total number randomized in the control group: 1033 |
Interventions
|
Intervention: 1 dose of 52 μmol of vitamin A (as retinyl palmitate) orally |
|
Control: Placebo (<0.10 μmol of vitamin A) orally |
|
Common intervention given to all groups: 23 μmol vitamin E (as dl‐α‐tocopherol) orally |
Outcomes
|
Primary outcome: Infant Morbidity & Mortality |
|
Other outcomes: Diarrhea, fever, cough, rapid breathing, wheezing, otitis media, pneumonia, sepsis |
Notes
|
|